<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
55154-4615-2
</NDCCode>
<PackageDescription>
3360 TABLET in 1 BOTTLE, PLASTIC (55154-4615-2)
</PackageDescription>
<NDC11Code>
55154-4615-02
</NDC11Code>
<ProductNDC>
55154-4615
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Namenda
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Memantine Hydrochloride
</NonProprietaryName>
<DosageFormName>
TABLET
</DosageFormName>
<RouteName>
ORAL
</RouteName>
<StartMarketingDate>
20031016
</StartMarketingDate>
<EndMarketingDate>
20180331
</EndMarketingDate>
<MarketingCategoryName>
NDA
</MarketingCategoryName>
<ApplicationNumber>
NDA021487
</ApplicationNumber>
<LabelerName>
Cardinal Health
</LabelerName>
<SubstanceName>
MEMANTINE HYDROCHLORIDE
</SubstanceName>
<StrengthNumber>
10
</StrengthNumber>
<StrengthUnit>
mg/1
</StrengthUnit>
<Pharm_Classes>
NMDA Receptor Antagonists [MoA],N-methyl-D-aspartate Receptor Antagonist [EPC]
</Pharm_Classes>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2018-04-03
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20191231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20031016
</StartMarketingDatePackage>
<EndMarketingDatePackage>
20180331
</EndMarketingDatePackage>
<SamplePackage>
N
</SamplePackage>
</NDC>